8-K filing — Acadia Healthcare Company, Inc. (ACHC)
Filed: 2026-09-25 AccNo: 0001437749-26-031225 Size: 755 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Crypto · News reference
Ten stocks have over 34% of their float short, with ONDS and BROS on the list led by VG.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-25 AccNo: 0001437749-26-031225 Size: 755 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
SUMMARY NOTICE OF PROPOSED SETTLEMENTTO: ALL RECORD OR BENEFICIAL OWNERS OF THE COMMON STOCK OF ACADIA HEALTHCARE COMPANY, INC. ("ACADIA" OR THE "COMPANY") AS OF JULY 31, 2026.YOU ARE HEREBY NOTIFIED,
Leerink Partners analyst Whit Mayo maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Market Perform and raises the price target from $30 to $33.
Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
Cathie Wood's Ark Invest added to positions in Meta Platforms, Airbnb, and Beam Therapeutics on Monday. Meta surged 11% on momentum from its new Muse AI app and an upgraded price target from Wells Fargo. Airbnb continues strong revenue growth despite headwinds from rising travel costs and regulatory scrutiny. Beam Therapeutics is recovering after recent clinical trial data showed efficacy in its gene-editing treatment for alpha-1 antitrypsin deficiency.
Dutch Bros stock has declined 55% from its peak but presents potential growth opportunities. Management targets 2,029 stores by 2029 (up from 1,225), which could drive a 66% stock increase if achieved, turning a $10,000 investment into $16,600. However, intense competition from major players like Starbucks, McDonald's, and Dunkin' poses significant headwinds to sustained expansion.